nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—SLC18A2—telencephalic ventricle—epilepsy syndrome	0.0233	0.161	CbGeAlD
Rescinnamine—ACE—forelimb—epilepsy syndrome	0.0183	0.126	CbGeAlD
Rescinnamine—ACE—autonomic nervous system—epilepsy syndrome	0.0178	0.123	CbGeAlD
Rescinnamine—SLC18A2—ganglion—epilepsy syndrome	0.0145	0.1	CbGeAlD
Rescinnamine—ACE—ganglion—epilepsy syndrome	0.0099	0.0683	CbGeAlD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—ATP6AP2—epilepsy syndrome	0.00956	0.0328	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—KCNK9—epilepsy syndrome	0.00951	0.0326	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—KCNK3—epilepsy syndrome	0.00951	0.0326	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—ATP6AP2—epilepsy syndrome	0.0091	0.0312	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—CLN8—epilepsy syndrome	0.00891	0.0305	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—BDKRB1—epilepsy syndrome	0.00728	0.0249	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopamine Neurotransmitter Release Cycle—SYN1—epilepsy syndrome	0.00713	0.0244	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopamine Neurotransmitter Release Cycle—STXBP1—epilepsy syndrome	0.00694	0.0238	CbGpPWpGaD
Rescinnamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—STXBP1—epilepsy syndrome	0.00694	0.0238	CbGpPWpGaD
Rescinnamine—SLC18A2—brainstem—epilepsy syndrome	0.0063	0.0435	CbGeAlD
Rescinnamine—SLC18A2—forebrain—epilepsy syndrome	0.00608	0.042	CbGeAlD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—ASCL1—epilepsy syndrome	0.00593	0.0203	CbGpPWpGaD
Rescinnamine—SLC18A2—telencephalon—epilepsy syndrome	0.00559	0.0386	CbGeAlD
Rescinnamine—ACE—ACE Inhibitor Pathway—BDKRB2—epilepsy syndrome	0.00504	0.0173	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—RET—epilepsy syndrome	0.00461	0.0158	CbGpPWpGaD
Rescinnamine—SLC18A2—medulla oblongata—epilepsy syndrome	0.00439	0.0303	CbGeAlD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—epilepsy syndrome	0.00417	0.0143	CbGpPWpGaD
Rescinnamine—ACE—forebrain—epilepsy syndrome	0.00415	0.0286	CbGeAlD
Rescinnamine—SLC18A2—midbrain—epilepsy syndrome	0.00402	0.0277	CbGeAlD
Rescinnamine—ACE—telencephalon—epilepsy syndrome	0.00382	0.0263	CbGeAlD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—epilepsy syndrome	0.00365	0.0125	CbGpPWpGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SYN1—epilepsy syndrome	0.00362	0.0124	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—STX1B—epilepsy syndrome	0.00355	0.0122	CbGpPWpGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—STXBP1—epilepsy syndrome	0.00352	0.0121	CbGpPWpGaD
Rescinnamine—SLC18A2—head—epilepsy syndrome	0.00348	0.024	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC1A1—epilepsy syndrome	0.00343	0.0118	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—epilepsy syndrome	0.00337	0.0116	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—epilepsy syndrome	0.00331	0.0113	CbGpPWpGaD
Rescinnamine—SLC18A2—nervous system—epilepsy syndrome	0.0033	0.0228	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—ABAT—epilepsy syndrome	0.00327	0.0112	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGT—epilepsy syndrome	0.00321	0.011	CbGpPWpGaD
Rescinnamine—SLC18A2—central nervous system—epilepsy syndrome	0.00318	0.0219	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC17A7—epilepsy syndrome	0.00314	0.0108	CbGpPWpGaD
Rescinnamine—SLC18A2—cerebellum—epilepsy syndrome	0.00311	0.0214	CbGeAlD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SYN1—epilepsy syndrome	0.0031	0.0106	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—NSF—epilepsy syndrome	0.0031	0.0106	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—STXBP1—epilepsy syndrome	0.00301	0.0103	CbGpPWpGaD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC6A1—epilepsy syndrome	0.00289	0.00992	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—CACNA1A—epilepsy syndrome	0.0028	0.00961	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—TH—epilepsy syndrome	0.00274	0.0094	CbGpPWpGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—GAD2—epilepsy syndrome	0.00274	0.0094	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC17A7—epilepsy syndrome	0.00269	0.00921	CbGpPWpGaD
Rescinnamine—ACE—spinal cord—epilepsy syndrome	0.00268	0.0185	CbGeAlD
Rescinnamine—SLC18A2—brain—epilepsy syndrome	0.00252	0.0174	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—ATP6AP2—epilepsy syndrome	0.00251	0.00861	CbGpPWpGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—GAD1—epilepsy syndrome	0.00238	0.00815	CbGpPWpGaD
Rescinnamine—ACE—head—epilepsy syndrome	0.00238	0.0164	CbGeAlD
Rescinnamine—ACE—nervous system—epilepsy syndrome	0.00225	0.0156	CbGeAlD
Rescinnamine—Reserpine—ABCC2—epilepsy syndrome	0.00224	0.23	CrCbGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—epilepsy syndrome	0.00221	0.00758	CbGpPWpGaD
Rescinnamine—ACE—central nervous system—epilepsy syndrome	0.00217	0.015	CbGeAlD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC1A3—epilepsy syndrome	0.00212	0.00728	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—TH—epilepsy syndrome	0.00206	0.00707	CbGpPWpGaD
Rescinnamine—Yohimbine—ADRA2A—epilepsy syndrome	0.00178	0.184	CrCbGaD
Rescinnamine—ACE—brain—epilepsy syndrome	0.00172	0.0119	CbGeAlD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CACNG3—epilepsy syndrome	0.00157	0.00537	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIK5—epilepsy syndrome	0.00157	0.00537	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—epilepsy syndrome	0.00151	0.00519	CbGpPWpGaD
Rescinnamine—Voacamine—ABCB1—epilepsy syndrome	0.00151	0.156	CrCbGaD
Rescinnamine—SLC18A2—Neuronal System—KCNQ4—epilepsy syndrome	0.00147	0.00505	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNC1—epilepsy syndrome	0.00147	0.00505	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNC4—epilepsy syndrome	0.00147	0.00505	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CACNG2—epilepsy syndrome	0.00146	0.005	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—BCHE—epilepsy syndrome	0.00144	0.00495	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00139	0.00476	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00139	0.00476	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00139	0.00476	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNA2—epilepsy syndrome	0.00137	0.0047	CbGpPWpGaD
Rescinnamine—Yohimbine—SLC6A4—epilepsy syndrome	0.00136	0.14	CrCbGaD
Rescinnamine—SLC18A2—Neuronal System—KCND2—epilepsy syndrome	0.00131	0.0045	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNAB2—epilepsy syndrome	0.00131	0.0045	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CACNA2D2—epilepsy syndrome	0.0013	0.00445	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CACNB4—epilepsy syndrome	0.0013	0.00445	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—VDAC1—epilepsy syndrome	0.00128	0.00439	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00127	0.00436	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRG2—epilepsy syndrome	0.00124	0.00425	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIK5—epilepsy syndrome	0.0012	0.00412	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CACNG3—epilepsy syndrome	0.0012	0.00412	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNK3—epilepsy syndrome	0.0012	0.00412	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNK9—epilepsy syndrome	0.0012	0.00412	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	0.00113	0.00388	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CACNG2—epilepsy syndrome	0.00112	0.00383	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—HCN1—epilepsy syndrome	0.00112	0.00383	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNV1—epilepsy syndrome	0.00112	0.00383	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00105	0.00361	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00105	0.00361	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00105	0.00361	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHRNA2—epilepsy syndrome	0.00105	0.0036	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNQ3—epilepsy syndrome	0.00105	0.0036	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNQ2—epilepsy syndrome	0.00105	0.0036	CbGpPWpGaD
Rescinnamine—Yohimbine—HTR2A—epilepsy syndrome	0.00105	0.108	CrCbGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.00104	0.00356	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.00104	0.00356	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.00101	0.00346	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.001	0.00344	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CACNB4—epilepsy syndrome	0.000995	0.00341	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CACNA2D2—epilepsy syndrome	0.000995	0.00341	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNB1—epilepsy syndrome	0.000995	0.00341	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.000985	0.00338	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PIGN—epilepsy syndrome	0.000971	0.00333	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PIGT—epilepsy syndrome	0.000971	0.00333	CbGpPWpGaD
Rescinnamine—Yohimbine—CYP2D6—epilepsy syndrome	0.000956	0.0984	CrCbGaD
Rescinnamine—SLC18A2—Neuronal System—GABRG2—epilepsy syndrome	0.00095	0.00326	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNH1—epilepsy syndrome	0.00095	0.00326	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000939	0.00322	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000939	0.00322	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000939	0.00322	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000939	0.00322	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000939	0.00322	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000901	0.00309	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000901	0.00309	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000901	0.00309	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000901	0.00309	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GOSR2—epilepsy syndrome	0.000888	0.00304	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—AGT—epilepsy syndrome	0.000886	0.00304	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000883	0.00303	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000867	0.00297	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000837	0.00287	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000837	0.00287	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000837	0.00287	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000826	0.00283	CbGpPWpGaD
Rescinnamine—Reserpine—ABCB1—epilepsy syndrome	0.000822	0.0847	CrCbGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000819	0.00281	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000799	0.00274	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000798	0.00274	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000798	0.00274	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SYN1—epilepsy syndrome	0.000796	0.00273	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—NSF—epilepsy syndrome	0.000796	0.00273	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000792	0.00272	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000792	0.00272	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000787	0.0027	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—STXBP1—epilepsy syndrome	0.000774	0.00265	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC1A1—epilepsy syndrome	0.000754	0.00259	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000746	0.00256	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.00073	0.0025	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNJ10—epilepsy syndrome	0.00072	0.00247	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIA4—epilepsy syndrome	0.00072	0.00247	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CACNA1A—epilepsy syndrome	0.00072	0.00247	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ABAT—epilepsy syndrome	0.00072	0.00247	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GABRA5—epilepsy syndrome	0.00072	0.00247	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000712	0.00244	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000712	0.00244	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000706	0.00242	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000706	0.00242	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000706	0.00242	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ARHGEF9—epilepsy syndrome	0.00069	0.00237	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC17A7—epilepsy syndrome	0.00069	0.00237	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GABRA1—epilepsy syndrome	0.00069	0.00237	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GABRB3—epilepsy syndrome	0.00069	0.00237	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000683	0.00234	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000679	0.00233	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GLUL—epilepsy syndrome	0.000677	0.00232	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—NEU1—epilepsy syndrome	0.000673	0.00231	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.000673	0.00231	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIA2—epilepsy syndrome	0.000664	0.00228	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000651	0.00223	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000646	0.00221	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIK1—epilepsy syndrome	0.000641	0.0022	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CHRNA7—epilepsy syndrome	0.000641	0.0022	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC1A2—epilepsy syndrome	0.000641	0.0022	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000635	0.00218	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000635	0.00218	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000635	0.00218	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000626	0.00215	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000626	0.00215	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GABRB2—epilepsy syndrome	0.000612	0.0021	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GAD2—epilepsy syndrome	0.000603	0.00207	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000601	0.00206	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000598	0.00205	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000588	0.00202	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000577	0.00198	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNMA1—epilepsy syndrome	0.000572	0.00196	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000565	0.00194	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ADD1—epilepsy syndrome	0.000558	0.00191	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000546	0.00187	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIK2—epilepsy syndrome	0.000545	0.00187	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC1A3—epilepsy syndrome	0.000545	0.00187	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNJ11—epilepsy syndrome	0.000545	0.00187	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000535	0.00183	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000535	0.00183	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000535	0.00183	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GAD1—epilepsy syndrome	0.000523	0.00179	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.000521	0.00179	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000514	0.00176	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000511	0.00175	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000511	0.00175	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.0005	0.00171	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GABBR1—epilepsy syndrome	0.000499	0.00171	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIA1—epilepsy syndrome	0.000486	0.00167	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC6A1—epilepsy syndrome	0.000486	0.00167	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—GRIN2A—epilepsy syndrome	0.000486	0.00167	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000481	0.00165	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000474	0.00163	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000469	0.00161	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000463	0.000836	CcSEcCtD
Rescinnamine—Urticaria—Fosphenytoin—epilepsy syndrome	0.000461	0.000833	CcSEcCtD
Rescinnamine—Pain—Felbamate—epilepsy syndrome	0.000461	0.000833	CcSEcCtD
Rescinnamine—Constipation—Felbamate—epilepsy syndrome	0.000461	0.000833	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—CHRNB2—epilepsy syndrome	0.00046	0.00158	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.00046	0.000831	CcSEcCtD
Rescinnamine—Nausea—Lacosamide—epilepsy syndrome	0.00046	0.000831	CcSEcCtD
Rescinnamine—Insomnia—Clonazepam—epilepsy syndrome	0.00046	0.000831	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000459	0.00157	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000458	0.000827	CcSEcCtD
Rescinnamine—Insomnia—Phenytoin—epilepsy syndrome	0.000457	0.000825	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000455	0.000823	CcSEcCtD
Rescinnamine—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000454	0.000821	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000454	0.00156	CbGpPWpGaD
Rescinnamine—Paraesthesia—Phenytoin—epilepsy syndrome	0.000454	0.000819	CcSEcCtD
Rescinnamine—Sinusitis—Gabapentin—epilepsy syndrome	0.000452	0.000816	CcSEcCtD
Rescinnamine—Constipation—Zonisamide—epilepsy syndrome	0.000451	0.000815	CcSEcCtD
Rescinnamine—Urticaria—Vigabatrin—epilepsy syndrome	0.000449	0.000812	CcSEcCtD
Rescinnamine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000449	0.00081	CcSEcCtD
Rescinnamine—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000447	0.000808	CcSEcCtD
Rescinnamine—Nausea—Clobazam—epilepsy syndrome	0.000447	0.000807	CcSEcCtD
Rescinnamine—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000444	0.000803	CcSEcCtD
Rescinnamine—Dizziness—Acetazolamide—epilepsy syndrome	0.000443	0.0008	CcSEcCtD
Rescinnamine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000443	0.0008	CcSEcCtD
Rescinnamine—Urticaria—Diazepam—epilepsy syndrome	0.000442	0.000799	CcSEcCtD
Rescinnamine—Angina pectoris—Topiramate—epilepsy syndrome	0.000442	0.000799	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000441	0.000796	CcSEcCtD
Rescinnamine—Pruritus—Propofol—epilepsy syndrome	0.00044	0.000795	CcSEcCtD
Rescinnamine—Abdominal pain—Diazepam—epilepsy syndrome	0.00044	0.000795	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000439	0.000793	CcSEcCtD
Rescinnamine—Back pain—Valproic Acid—epilepsy syndrome	0.000439	0.000793	CcSEcCtD
Rescinnamine—Bronchitis—Topiramate—epilepsy syndrome	0.000437	0.000789	CcSEcCtD
Rescinnamine—Insomnia—Carbamazepine—epilepsy syndrome	0.000436	0.000788	CcSEcCtD
Rescinnamine—Constipation—Clonazepam—epilepsy syndrome	0.000435	0.000785	CcSEcCtD
Rescinnamine—Pain—Clonazepam—epilepsy syndrome	0.000435	0.000785	CcSEcCtD
Rescinnamine—Rhinitis—Gabapentin—epilepsy syndrome	0.000433	0.000782	CcSEcCtD
Rescinnamine—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000433	0.000782	CcSEcCtD
Rescinnamine—Constipation—Phenytoin—epilepsy syndrome	0.000432	0.00078	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000431	0.000779	CcSEcCtD
Rescinnamine—Pruritus—Midazolam—epilepsy syndrome	0.000431	0.000778	CcSEcCtD
Rescinnamine—Hypoaesthesia—Gabapentin—epilepsy syndrome	0.00043	0.000777	CcSEcCtD
Rescinnamine—Pain—Oxcarbazepine—epilepsy syndrome	0.00043	0.000776	CcSEcCtD
Rescinnamine—Constipation—Oxcarbazepine—epilepsy syndrome	0.00043	0.000776	CcSEcCtD
Rescinnamine—Pharyngitis—Gabapentin—epilepsy syndrome	0.000429	0.000775	CcSEcCtD
Rescinnamine—Urticaria—Felbamate—epilepsy syndrome	0.000428	0.000774	CcSEcCtD
Rescinnamine—Abdominal pain—Felbamate—epilepsy syndrome	0.000426	0.00077	CcSEcCtD
Rescinnamine—Pruritus—Levetiracetam—epilepsy syndrome	0.000425	0.000768	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000425	0.000767	CcSEcCtD
Rescinnamine—Insomnia—Lamotrigine—epilepsy syndrome	0.000421	0.000761	CcSEcCtD
Rescinnamine—Headache—Acetazolamide—epilepsy syndrome	0.00042	0.000758	CcSEcCtD
Rescinnamine—Urticaria—Zonisamide—epilepsy syndrome	0.000419	0.000757	CcSEcCtD
Rescinnamine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000418	0.000756	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—CHRNA4—epilepsy syndrome	0.000418	0.00143	CbGpPWpGaD
Rescinnamine—Abdominal pain—Zonisamide—epilepsy syndrome	0.000417	0.000753	CcSEcCtD
Rescinnamine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000417	0.000753	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000416	0.00143	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000416	0.000751	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Topiramate—epilepsy syndrome	0.000415	0.000749	CcSEcCtD
Rescinnamine—Pain—Carbamazepine—epilepsy syndrome	0.000412	0.000745	CcSEcCtD
Rescinnamine—Constipation—Carbamazepine—epilepsy syndrome	0.000412	0.000745	CcSEcCtD
Rescinnamine—Dizziness—Propofol—epilepsy syndrome	0.000412	0.000743	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000411	0.000742	CcSEcCtD
Rescinnamine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000411	0.000742	CcSEcCtD
Rescinnamine—Hypersensitivity—Diazepam—epilepsy syndrome	0.00041	0.000741	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000406	0.00139	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000406	0.00139	CbGpPWpGaD
Rescinnamine—Urticaria—Clonazepam—epilepsy syndrome	0.000404	0.00073	CcSEcCtD
Rescinnamine—Dizziness—Midazolam—epilepsy syndrome	0.000403	0.000727	CcSEcCtD
Rescinnamine—Abdominal pain—Clonazepam—epilepsy syndrome	0.000402	0.000726	CcSEcCtD
Rescinnamine—Dysgeusia—Pregabalin—epilepsy syndrome	0.000402	0.000726	CcSEcCtD
Rescinnamine—Urticaria—Phenytoin—epilepsy syndrome	0.000401	0.000725	CcSEcCtD
Rescinnamine—Pruritus—Vigabatrin—epilepsy syndrome	0.0004	0.000723	CcSEcCtD
Rescinnamine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000399	0.000721	CcSEcCtD
Rescinnamine—Pain—Lamotrigine—epilepsy syndrome	0.000398	0.00072	CcSEcCtD
Rescinnamine—Constipation—Lamotrigine—epilepsy syndrome	0.000398	0.00072	CcSEcCtD
Rescinnamine—Nausea—Acetazolamide—epilepsy syndrome	0.000398	0.000719	CcSEcCtD
Rescinnamine—Dizziness—Levetiracetam—epilepsy syndrome	0.000398	0.000718	CcSEcCtD
Rescinnamine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000397	0.000717	CcSEcCtD
Rescinnamine—Back pain—Pregabalin—epilepsy syndrome	0.000397	0.000717	CcSEcCtD
Rescinnamine—Cough—Valproic Acid—epilepsy syndrome	0.000396	0.000715	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000394	0.000712	CcSEcCtD
Rescinnamine—Pruritus—Diazepam—epilepsy syndrome	0.000394	0.000712	CcSEcCtD
Rescinnamine—Urinary tract infection—Topiramate—epilepsy syndrome	0.000394	0.000711	CcSEcCtD
Rescinnamine—Conjunctivitis—Topiramate—epilepsy syndrome	0.000394	0.000711	CcSEcCtD
Rescinnamine—Rash—Propofol—epilepsy syndrome	0.000392	0.000709	CcSEcCtD
Rescinnamine—Dermatitis—Propofol—epilepsy syndrome	0.000392	0.000708	CcSEcCtD
Rescinnamine—Hypertension—Valproic Acid—epilepsy syndrome	0.000392	0.000708	CcSEcCtD
Rescinnamine—Headache—Propofol—epilepsy syndrome	0.00039	0.000704	CcSEcCtD
Rescinnamine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000389	0.000702	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000387	0.00133	CbGpPWpGaD
Rescinnamine—Myalgia—Valproic Acid—epilepsy syndrome	0.000386	0.000698	CcSEcCtD
Rescinnamine—Rash—Midazolam—epilepsy syndrome	0.000384	0.000694	CcSEcCtD
Rescinnamine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000384	0.000693	CcSEcCtD
Rescinnamine—Dermatitis—Midazolam—epilepsy syndrome	0.000384	0.000693	CcSEcCtD
Rescinnamine—Urticaria—Carbamazepine—epilepsy syndrome	0.000383	0.000692	CcSEcCtD
Rescinnamine—Discomfort—Valproic Acid—epilepsy syndrome	0.000382	0.000689	CcSEcCtD
Rescinnamine—Headache—Midazolam—epilepsy syndrome	0.000381	0.000689	CcSEcCtD
Rescinnamine—Pruritus—Felbamate—epilepsy syndrome	0.000381	0.000689	CcSEcCtD
Rescinnamine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000381	0.000688	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000381	0.000688	CcSEcCtD
Rescinnamine—Sinusitis—Topiramate—epilepsy syndrome	0.00038	0.000686	CcSEcCtD
Rescinnamine—Rash—Levetiracetam—epilepsy syndrome	0.000379	0.000685	CcSEcCtD
Rescinnamine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000379	0.000684	CcSEcCtD
Rescinnamine—Headache—Levetiracetam—epilepsy syndrome	0.000377	0.00068	CcSEcCtD
Rescinnamine—Erythema—Gabapentin—epilepsy syndrome	0.000376	0.000679	CcSEcCtD
Rescinnamine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000375	0.000677	CcSEcCtD
Rescinnamine—Dizziness—Vigabatrin—epilepsy syndrome	0.000374	0.000676	CcSEcCtD
Rescinnamine—Pruritus—Zonisamide—epilepsy syndrome	0.000373	0.000674	CcSEcCtD
Rescinnamine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000372	0.000672	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000372	0.00127	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000371	0.00127	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000371	0.00127	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000371	0.00127	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000371	0.00127	CbGpPWpGaD
Rescinnamine—Oedema—Valproic Acid—epilepsy syndrome	0.00037	0.000669	CcSEcCtD
Rescinnamine—Urticaria—Lamotrigine—epilepsy syndrome	0.00037	0.000669	CcSEcCtD
Rescinnamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00037	0.000669	CcSEcCtD
Rescinnamine—Nausea—Propofol—epilepsy syndrome	0.00037	0.000668	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—BCHE—epilepsy syndrome	0.000368	0.00126	CbGpPWpGaD
Rescinnamine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000368	0.000665	CcSEcCtD
Rescinnamine—Dysgeusia—Gabapentin—epilepsy syndrome	0.000368	0.000665	CcSEcCtD
Rescinnamine—Dizziness—Diazepam—epilepsy syndrome	0.000368	0.000665	CcSEcCtD
Rescinnamine—Infection—Valproic Acid—epilepsy syndrome	0.000368	0.000664	CcSEcCtD
Rescinnamine—Rash—Fosphenytoin—epilepsy syndrome	0.000366	0.000661	CcSEcCtD
Rescinnamine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000366	0.00066	CcSEcCtD
Rescinnamine—Rhinitis—Topiramate—epilepsy syndrome	0.000364	0.000658	CcSEcCtD
Rescinnamine—Back pain—Gabapentin—epilepsy syndrome	0.000364	0.000657	CcSEcCtD
Rescinnamine—Headache—Fosphenytoin—epilepsy syndrome	0.000364	0.000657	CcSEcCtD
Rescinnamine—Nausea—Midazolam—epilepsy syndrome	0.000362	0.000653	CcSEcCtD
Rescinnamine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000362	0.000653	CcSEcCtD
Rescinnamine—Pharyngitis—Topiramate—epilepsy syndrome	0.000361	0.000652	CcSEcCtD
Rescinnamine—Pruritus—Clonazepam—epilepsy syndrome	0.00036	0.00065	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—DLG4—epilepsy syndrome	0.00036	0.00123	CbGpPWpGaD
Rescinnamine—Cough—Pregabalin—epilepsy syndrome	0.000358	0.000647	CcSEcCtD
Rescinnamine—Pruritus—Phenytoin—epilepsy syndrome	0.000357	0.000646	CcSEcCtD
Rescinnamine—Nausea—Levetiracetam—epilepsy syndrome	0.000357	0.000645	CcSEcCtD
Rescinnamine—Rash—Vigabatrin—epilepsy syndrome	0.000357	0.000644	CcSEcCtD
Rescinnamine—Dizziness—Felbamate—epilepsy syndrome	0.000356	0.000644	CcSEcCtD
Rescinnamine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000356	0.000644	CcSEcCtD
Rescinnamine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000355	0.000642	CcSEcCtD
Rescinnamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000355	0.000642	CcSEcCtD
Rescinnamine—Headache—Vigabatrin—epilepsy syndrome	0.000354	0.00064	CcSEcCtD
Rescinnamine—Hypertension—Pregabalin—epilepsy syndrome	0.000354	0.00064	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GRIN2B—epilepsy syndrome	0.000351	0.0012	CbGpPWpGaD
Rescinnamine—Rash—Diazepam—epilepsy syndrome	0.000351	0.000634	CcSEcCtD
Rescinnamine—Dermatitis—Diazepam—epilepsy syndrome	0.000351	0.000634	CcSEcCtD
Rescinnamine—Myalgia—Pregabalin—epilepsy syndrome	0.000349	0.000631	CcSEcCtD
Rescinnamine—Dizziness—Zonisamide—epilepsy syndrome	0.000349	0.00063	CcSEcCtD
Rescinnamine—Headache—Diazepam—epilepsy syndrome	0.000349	0.00063	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—PLCB1—epilepsy syndrome	0.000348	0.00119	CbGpPWpGaD
Rescinnamine—Discomfort—Pregabalin—epilepsy syndrome	0.000345	0.000623	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000345	0.00118	CbGpPWpGaD
Rescinnamine—Nausea—Fosphenytoin—epilepsy syndrome	0.000345	0.000623	CcSEcCtD
Rescinnamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000343	0.00062	CcSEcCtD
Rescinnamine—Pruritus—Carbamazepine—epilepsy syndrome	0.000341	0.000616	CcSEcCtD
Rescinnamine—Rash—Felbamate—epilepsy syndrome	0.00034	0.000614	CcSEcCtD
Rescinnamine—Dermatitis—Felbamate—epilepsy syndrome	0.00034	0.000613	CcSEcCtD
Rescinnamine—Headache—Felbamate—epilepsy syndrome	0.000338	0.00061	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000337	0.000609	CcSEcCtD
Rescinnamine—Dizziness—Clonazepam—epilepsy syndrome	0.000336	0.000607	CcSEcCtD
Rescinnamine—Nausea—Vigabatrin—epilepsy syndrome	0.000336	0.000607	CcSEcCtD
Rescinnamine—Insomnia—Valproic Acid—epilepsy syndrome	0.000335	0.000605	CcSEcCtD
Rescinnamine—Oedema—Pregabalin—epilepsy syndrome	0.000335	0.000605	CcSEcCtD
Rescinnamine—Dizziness—Phenytoin—epilepsy syndrome	0.000334	0.000603	CcSEcCtD
Rescinnamine—Rash—Zonisamide—epilepsy syndrome	0.000333	0.000601	CcSEcCtD
Rescinnamine—Infection—Pregabalin—epilepsy syndrome	0.000333	0.000601	CcSEcCtD
Rescinnamine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000332	0.000601	CcSEcCtD
Rescinnamine—Dermatitis—Zonisamide—epilepsy syndrome	0.000332	0.0006	CcSEcCtD
Rescinnamine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000332	0.0006	CcSEcCtD
Rescinnamine—Nausea—Diazepam—epilepsy syndrome	0.000331	0.000598	CcSEcCtD
Rescinnamine—Headache—Zonisamide—epilepsy syndrome	0.000331	0.000597	CcSEcCtD
Rescinnamine—Pruritus—Lamotrigine—epilepsy syndrome	0.00033	0.000596	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000329	0.00113	CbGpPWpGaD
Rescinnamine—Cough—Gabapentin—epilepsy syndrome	0.000328	0.000593	CcSEcCtD
Rescinnamine—Hypertension—Gabapentin—epilepsy syndrome	0.000325	0.000587	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000324	0.00111	CbGpPWpGaD
Rescinnamine—Rash—Clonazepam—epilepsy syndrome	0.000321	0.000579	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.00032	0.0011	CbGpPWpGaD
Rescinnamine—Dermatitis—Clonazepam—epilepsy syndrome	0.00032	0.000579	CcSEcCtD
Rescinnamine—Myalgia—Gabapentin—epilepsy syndrome	0.00032	0.000578	CcSEcCtD
Rescinnamine—Nausea—Felbamate—epilepsy syndrome	0.00032	0.000578	CcSEcCtD
Rescinnamine—Dizziness—Carbamazepine—epilepsy syndrome	0.000319	0.000576	CcSEcCtD
Rescinnamine—Headache—Clonazepam—epilepsy syndrome	0.000319	0.000575	CcSEcCtD
Rescinnamine—Rash—Phenytoin—epilepsy syndrome	0.000318	0.000575	CcSEcCtD
Rescinnamine—Dermatitis—Phenytoin—epilepsy syndrome	0.000318	0.000575	CcSEcCtD
Rescinnamine—Rash—Oxcarbazepine—epilepsy syndrome	0.000317	0.000572	CcSEcCtD
Rescinnamine—Pain—Valproic Acid—epilepsy syndrome	0.000317	0.000572	CcSEcCtD
Rescinnamine—Constipation—Valproic Acid—epilepsy syndrome	0.000317	0.000572	CcSEcCtD
Rescinnamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000317	0.000572	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—ACTB—epilepsy syndrome	0.000316	0.00108	CbGpPWpGaD
Rescinnamine—Headache—Phenytoin—epilepsy syndrome	0.000316	0.000572	CcSEcCtD
Rescinnamine—Erythema—Topiramate—epilepsy syndrome	0.000316	0.000572	CcSEcCtD
Rescinnamine—Discomfort—Gabapentin—epilepsy syndrome	0.000316	0.000571	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000315	0.00108	CbGpPWpGaD
Rescinnamine—Headache—Oxcarbazepine—epilepsy syndrome	0.000315	0.000569	CcSEcCtD
Rescinnamine—Nausea—Zonisamide—epilepsy syndrome	0.000313	0.000566	CcSEcCtD
Rescinnamine—Dysgeusia—Topiramate—epilepsy syndrome	0.00031	0.00056	CcSEcCtD
Rescinnamine—Dizziness—Lamotrigine—epilepsy syndrome	0.000308	0.000557	CcSEcCtD
Rescinnamine—Oedema—Gabapentin—epilepsy syndrome	0.000307	0.000554	CcSEcCtD
Rescinnamine—Back pain—Topiramate—epilepsy syndrome	0.000306	0.000553	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000305	0.000551	CcSEcCtD
Rescinnamine—Infection—Gabapentin—epilepsy syndrome	0.000305	0.000551	CcSEcCtD
Rescinnamine—Rash—Carbamazepine—epilepsy syndrome	0.000304	0.000549	CcSEcCtD
Rescinnamine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000304	0.000549	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000304	0.00104	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000303	0.00104	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000303	0.000547	CcSEcCtD
Rescinnamine—Insomnia—Pregabalin—epilepsy syndrome	0.000303	0.000547	CcSEcCtD
Rescinnamine—Nausea—Clonazepam—epilepsy syndrome	0.000302	0.000546	CcSEcCtD
Rescinnamine—Headache—Carbamazepine—epilepsy syndrome	0.000302	0.000546	CcSEcCtD
Rescinnamine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000301	0.000543	CcSEcCtD
Rescinnamine—Nausea—Phenytoin—epilepsy syndrome	0.0003	0.000542	CcSEcCtD
Rescinnamine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000298	0.000539	CcSEcCtD
Rescinnamine—Urticaria—Valproic Acid—epilepsy syndrome	0.000294	0.000531	CcSEcCtD
Rescinnamine—Rash—Lamotrigine—epilepsy syndrome	0.000294	0.000531	CcSEcCtD
Rescinnamine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000294	0.00053	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000293	0.00101	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000293	0.00101	CbGpPWpGaD
Rescinnamine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000293	0.000529	CcSEcCtD
Rescinnamine—Headache—Lamotrigine—epilepsy syndrome	0.000292	0.000527	CcSEcCtD
Rescinnamine—Nausea—Carbamazepine—epilepsy syndrome	0.000286	0.000517	CcSEcCtD
Rescinnamine—Constipation—Pregabalin—epilepsy syndrome	0.000286	0.000517	CcSEcCtD
Rescinnamine—Pain—Pregabalin—epilepsy syndrome	0.000286	0.000517	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000281	0.000964	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.00028	0.000505	CcSEcCtD
Rescinnamine—Insomnia—Gabapentin—epilepsy syndrome	0.000278	0.000501	CcSEcCtD
Rescinnamine—Nausea—Lamotrigine—epilepsy syndrome	0.000277	0.0005	CcSEcCtD
Rescinnamine—Cough—Topiramate—epilepsy syndrome	0.000276	0.000499	CcSEcCtD
Rescinnamine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000276	0.000498	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000274	0.000494	CcSEcCtD
Rescinnamine—Hypertension—Topiramate—epilepsy syndrome	0.000273	0.000493	CcSEcCtD
Rescinnamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000273	0.000493	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	0.000273	0.000935	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—BCHE—epilepsy syndrome	0.000272	0.000934	CbGpPWpGaD
Rescinnamine—Myalgia—Topiramate—epilepsy syndrome	0.000269	0.000487	CcSEcCtD
Rescinnamine—Discomfort—Topiramate—epilepsy syndrome	0.000266	0.000481	CcSEcCtD
Rescinnamine—Urticaria—Pregabalin—epilepsy syndrome	0.000266	0.00048	CcSEcCtD
Rescinnamine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000265	0.000478	CcSEcCtD
Rescinnamine—Pain—Gabapentin—epilepsy syndrome	0.000262	0.000474	CcSEcCtD
Rescinnamine—Constipation—Gabapentin—epilepsy syndrome	0.000262	0.000474	CcSEcCtD
Rescinnamine—Pruritus—Valproic Acid—epilepsy syndrome	0.000262	0.000473	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000261	0.000896	CbGpPWpGaD
Rescinnamine—Oedema—Topiramate—epilepsy syndrome	0.000258	0.000466	CcSEcCtD
Rescinnamine—Infection—Topiramate—epilepsy syndrome	0.000257	0.000463	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000251	0.000453	CcSEcCtD
Rescinnamine—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000247	0.000446	CcSEcCtD
Rescinnamine—Dizziness—Valproic Acid—epilepsy syndrome	0.000245	0.000442	CcSEcCtD
Rescinnamine—Urticaria—Gabapentin—epilepsy syndrome	0.000244	0.00044	CcSEcCtD
Rescinnamine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000243	0.000438	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000239	0.000819	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PLAUR—epilepsy syndrome	0.000237	0.000812	CbGpPWpGaD
Rescinnamine—Pruritus—Pregabalin—epilepsy syndrome	0.000237	0.000428	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000235	0.000425	CcSEcCtD
Rescinnamine—Insomnia—Topiramate—epilepsy syndrome	0.000234	0.000422	CcSEcCtD
Rescinnamine—Rash—Valproic Acid—epilepsy syndrome	0.000233	0.000422	CcSEcCtD
Rescinnamine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000233	0.000421	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000233	0.000799	CbGpPWpGaD
Rescinnamine—Headache—Valproic Acid—epilepsy syndrome	0.000232	0.000419	CcSEcCtD
Rescinnamine—Paraesthesia—Topiramate—epilepsy syndrome	0.000232	0.000419	CcSEcCtD
Rescinnamine—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000226	0.000409	CcSEcCtD
Rescinnamine—Dizziness—Pregabalin—epilepsy syndrome	0.000221	0.0004	CcSEcCtD
Rescinnamine—Pain—Topiramate—epilepsy syndrome	0.000221	0.000399	CcSEcCtD
Rescinnamine—Constipation—Topiramate—epilepsy syndrome	0.000221	0.000399	CcSEcCtD
Rescinnamine—Nausea—Valproic Acid—epilepsy syndrome	0.00022	0.000397	CcSEcCtD
Rescinnamine—Pruritus—Gabapentin—epilepsy syndrome	0.000217	0.000392	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000211	0.000381	CcSEcCtD
Rescinnamine—Rash—Pregabalin—epilepsy syndrome	0.000211	0.000381	CcSEcCtD
Rescinnamine—Dermatitis—Pregabalin—epilepsy syndrome	0.000211	0.000381	CcSEcCtD
Rescinnamine—Headache—Pregabalin—epilepsy syndrome	0.00021	0.000379	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—PRKCB—epilepsy syndrome	0.000209	0.000717	CbGpPWpGaD
Rescinnamine—Urticaria—Topiramate—epilepsy syndrome	0.000205	0.000371	CcSEcCtD
Rescinnamine—Abdominal pain—Topiramate—epilepsy syndrome	0.000204	0.000369	CcSEcCtD
Rescinnamine—Dizziness—Gabapentin—epilepsy syndrome	0.000203	0.000367	CcSEcCtD
Rescinnamine—Nausea—Pregabalin—epilepsy syndrome	0.000199	0.000359	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000198	0.000679	CbGpPWpGaD
Rescinnamine—Rash—Gabapentin—epilepsy syndrome	0.000194	0.00035	CcSEcCtD
Rescinnamine—Dermatitis—Gabapentin—epilepsy syndrome	0.000193	0.000349	CcSEcCtD
Rescinnamine—Headache—Gabapentin—epilepsy syndrome	0.000192	0.000347	CcSEcCtD
Rescinnamine—Hypersensitivity—Topiramate—epilepsy syndrome	0.00019	0.000344	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000189	0.000648	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000184	0.00063	CbGpPWpGaD
Rescinnamine—Pruritus—Topiramate—epilepsy syndrome	0.000183	0.00033	CcSEcCtD
Rescinnamine—Nausea—Gabapentin—epilepsy syndrome	0.000182	0.000329	CcSEcCtD
Rescinnamine—Dizziness—Topiramate—epilepsy syndrome	0.000171	0.000308	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—AGT—epilepsy syndrome	0.000167	0.000573	CbGpPWpGaD
Rescinnamine—Rash—Topiramate—epilepsy syndrome	0.000163	0.000294	CcSEcCtD
Rescinnamine—Dermatitis—Topiramate—epilepsy syndrome	0.000163	0.000294	CcSEcCtD
Rescinnamine—Headache—Topiramate—epilepsy syndrome	0.000162	0.000292	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000155	0.000533	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000154	0.000528	CbGpPWpGaD
Rescinnamine—Nausea—Topiramate—epilepsy syndrome	0.000153	0.000277	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000149	0.000511	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—epilepsy syndrome	0.000141	0.000483	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CCL2—epilepsy syndrome	0.000138	0.000472	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.33e-05	0.00032	CbGpPWpGaD
